The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2016 | Answering the first question AML patients ask – how did I get this?
Mark Levis, MD, PhD from The Johns Hopkins University, Baltimore, MD discusses a common question that acute myeloid leukemia (AML) patients ask on their first visit, “how did I get this?”. Today there is a much better understanding of AML and often its cause cannot be pinpointed to a patient’s actions but rather is caused by the natural increase of mutations with age. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.
